Meridian Bioscience offered SARS-CoV-2 antigens for COVID-19 antibody tests
On Apr. 14, 2020, Meridian Bioscience announced it had launched a series of recombinant antigens for high sensitivity…
-
-
AstraZeneca initiated CALAVI clinical trial with Calquence against COVID-19
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
-
Sanofi and GSK announced an unprecedented vaccine collaboration to fight COVID-19
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…
-
Sinovac announced approval of human clinical trial for a vaccine candidate against COVID-19
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Medicine | Therapeutics
Iceland provides picture of early spread of COVID-19 in population with cohesive public health response
On Apr. 14, 2020, scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital…
-
Philips joined forces with Flex and Jabil to speed the production of hospital ventilators
On Apr. 14, 2020, Philips announced that it had joined forces with manufacturing partners Flex and Jabil to…
-
New Philips Respironics E30 ventilator introduced to help free up ICU units in wake of COVID-19
On Apr. 14, 2020, Philips announced its initiative to quickly scale production of its new Philips Respironics E30…
-
NantKwest and ImmunityBio announced therapeutics and vaccines for combatting COVID-19
On Apr. 14, 2020, NantKwest and ImmunityBio announced discussions with the FDA for vaccines and therapeutics to combat…
-
RedHill Biopharma reported the first two patients treated with opaganib at a leading hospital in Israel
On Apr. 13, 2020, RedHill Biopharma provided an initial update on the compassionate use program with its investigational…
-
Pluristem treated first COVID-19 patient in US under FDA single patient expanded access program
On Apr. 13, 2020, Pluristem Therapeutics announced it has treated its first patient suffering from COVID-19 complications in…
-
Bausch Health initiated VIRAZOLEﾮ (Ribavirin for inhalation solution, USP) clinical study in patients with COVID-19
On Apr. 13, 2020, Bausch Health announced it has initiated a clinical trial program in Canada evaluating an…
-
Emory University developed diagnostic antibody blood test to determine antibody-responses to COVID-19
On Apr. 13, 2020, Emory University developed a sensitive and specific diagnostic antibody, also known as serological tests,…
-
Mayo Clinic Laboratories launched serology testing in support of COVID-19 response
On Apr. 13, 2020, a new serology test from Mayo Clinic Laboratories that is used to identify the…
-
BD announced second FDA Emergency Use Authorization, CE Mark for new COVID-19 molecular diagnostic for global use
On Apr. 13, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
-
FDA authorized Athersys to initiate pvotal clinical trial evaluating MultiStemﾮ cell therapy in patients with COVID-19 induced ARDS
On Apr. 13, 2020, Athersys announced the FDA has authorized the Company to initiate a Phase 2/3 pivotal…
-
Aegis Sciences launched test for Coronavirus disease 2019 (COVID-19)
On Apr. 13, 2020, Aegis Sciences announced serving as a regional reference laboratory for COVID-19 testing being directed…
-
Alberta Hope COVID-19 study tested early treatment option
On Apr. 13, 2020, COVID-19 study was announced that will recruit 1,600 Albertans to determine whether a prescribed…
-
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
-
Potential treatment for COVID-19 identified by BenevolentAI using artificial intelligence enters randomised clinical trial
On Apr. 10, 2020, BenevolentAI announced that baricitinib, which it had identified as a potential treatment for COVID-19,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medicine | Pharmaceutical | Therapeutics
Data on 53 patients treated with investigational antiviral remdesivir through Compassionate Use Program published in NEJM
On Apr. 10, 2020, Gilead Sciences announced results from a cohort analysis of 53 patients hospitalized with severe…
-
Terumo BCT and Marker Therapeutics received FDA Emergency Use Authorization to treat acute respiratory failure in COVID-19 patients
On Apr. 10, 2020, Terumo BCT and Marker Therapeutics announced the FDA issued an Emergency Use Authorization (EUA)…
-
Eli Lilly began clinical testing of therapies for COVID-19
On Apr. 10, 2020, Eli Lilly announced it had entered into an agreement with the National Institute of…
-
LabCorp and Ciox Health announced an agreement to create a comprehensive COVID-19 patient data registry
On Apr. 9, 2020, LabCorp and Ciox Health announced an agreement to collaborate on a comprehensive U.S.-based COVID-19…
-
BioCryst began clinical trial with Galidesivir for treatment of patients with COVID-19
On Apr. 9, 2020, BioCryst Pharmaceuticals announced the company has opened enrollment into a randomized, double-blind, placebo-controlled clinical…
-
Pfizer and BioNTech announced details on collaboration to accelerate global COVID-19 vaccine development
On Apr. 9, 2020, Pfizer and BioNTech disclosed additional details of their collaboration to advance candidates from BioNTech’s…
-
Chembio Diagnostics and Stony Brook Medicine collaborated to identify Coronavirus survivors
On Apr. 9, 2020, Chembio Diagnostics has been selected for use in a Stony Brook Medicine effort to…
-
iBio announced signing of agreements with Infectious Disease Research Institute in support of iBio’s SARS-CoV-2 Virus-Like Particle vaccine development
On Apr. 9, 2020, iBio announced the signing of two agreements with the Infectious Disease Research Institute (IDRI)…
-
Severely Ill COVID-19 patient at Southern California medical center extubated three days after treatment with CytoDyn’s leronlimab
On Apr. 9, 2020, CytoDyn announced a patient with severe COVID-19 under the care of a leading medical…
-
NIH began clinical trial of hydroxychloroquine as potential therapy for COVID-19
On Apr. 9, 2020, the first participants were enrolled in the trial at Vanderbilt University Medical Center, Nashville,…
-
Biotechnology | COVID-19 | Infectious Disease | Influenza | Medicine | Pharmaceutical | Therapeutics
Fujifilm announced the start of a phase II clinical trial of its influenza antiviral drug ‘Avigan’ Tablet for COVID-19 patients in the U.S.
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
